HLA Typing for Transplant Market is expected to grow at a CAGR of 6.7% during the forecast period and market is expected to reach US$ 1254.61 Mn. by 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report HLA Typing for Transplant Market growth is primarily driven by increasing demand for organ transplantation. Other factors such as rising aging population, and an increasing number of aged donors for the transplantation also drive the market for Global HLA Typing for Transplant Market through the forecast period.
HLA Typing for Transplant Market Overview By Region
North America expected to have larger market share due to rising demand for organ transplantation in the region. Another major factor that drives the HLA typing for the transplant market in this region is rising life expectancy and rising aged population. The factors including easy availability and increasing adoption of advanced diagnostic technologies such as PCR and NGS, and rising chronic diseases such as cancer, heart failure, and renal diseases in U.S. and Canada, also drive the market for HLA Typing for Transplant through the forecast period.HLA Typing for Transplant Market Overview By Applications
Diagnostics is expected to account for a higher market share in 2022. Global HLA Typing for Transplant Market is driven due to increased demand for techniques used to match the organ or tissue with the donor’s compatibility. Further increasing research and development activities in the diagnostic centers also drive the market for HLA typing for transplant through the forecast period.HLA Typing for Transplant Market Overview By Products & Services
In 2016, the Instrumentation segment had the highest market share. The market has the highest share due to some factors such as, advancement in the technology, technology that provide accurate and better results, rising investment on the diagnostic instruments.HLA Typing for Transplant Market Overview By End-Use
Hospitals segment had the highest market share in 2022. The high demand for hospital HLA typing for transplant is due to the factors such as, rising demand for organ transplantations, advancement in technology and instruments of the hospitals throughout the globe, and the rise in disposable income of people which can be spent in hospitals.
HLA Typing for Transplant Market Overview By Technology
Molecular Assays had the market share in 2022. This is due to increasing demand for molecular tests, and the technology used in molecular assays. The technologies used in this test are highly accurate and the tests can be done with the faster pace. Molecular assays help in next-generation sequencing and, they are capable for the considerable number of process sequences and thus, creates huge demand for adoption. A rising number of solid organ and stem cell transplantation procedures and the increasing number of transplant research centers also drive the Global HLA Typing for Transplant Market.HLA Typing for Transplant Market Background
Developing countries such as China and India are increasing their investments in the healthcare sectors. Other private organizations in the developing countries also investing in the healthcare infrastructures. These factors drive the market for HLA Typing for Transplant through the forecast period. The objective of the report is to present comprehensive analysis of Global HLA Typing for Transplant market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Global HLA Typing for Transplant market dynamics, structure by analyzing the market segments, and project the Global HLA Typing for Transplant market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global HLA Typing for Transplant market make the report investor’s guide.HLA Typing for Transplant Market Scope: Inquire before buying
HLA Typing for Transplant Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 796.81 Mn. Forecast Period 2023 to 2029 CAGR: 6.7% Market Size in 2029: US $ 1254.61 Mn. Segments Covered: by Technology • Non-Molecular Assays • Serological Assays • Mixed Lymphocyte Culture Assay • Molecular Assays • PCR based Molecular Assays • Sequencing based molecular Assays by Products • Instruments • Reagents • Software by Application • Diagnostics • Research by End-User • Hospitals • Academic & Research Institute HLA Typing for Transplant Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)HLA Typing for Transplant Market Key Players
• Thermo Fischer Scientific, Inc., • Immucor, Inc. • Olerup SSp AB • QIAGEN, Inc • Bio-Rad Laboratories, Inc. • Affymetrix, Inc. • Illumina Inc. • Luminex Corporation • F. Hoffmann-La Roche Ltd • Abbott Laboratories, Inc. • CareDx Inc • GenDx • Voden Medical Instruments S.p.a. • TBG Diagnostics Limited • ProImmune Ltd • Pacific Biosciences of California, Inc • Omixon Inc. • omicX • MC Diagnostics Ltd • Integrated Gulf Biosystems • InGen Frequently Asked Questions: 1. Which region has the largest share in Global HLA Typing for Transplant Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global HLA Typing for Transplant Market? Ans: The Global HLA Typing for Transplant Market is growing at a CAGR of 6.7% during forecasting period 2023-2029. 3. What is scope of the Global HLA Typing for Transplant Market report? Ans: Global HLA Typing for Transplant Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global HLA Typing for Transplant Market? Ans: The important key players in the Global HLA Typing for Transplant Market are – Thermo Fischer Scientific, Inc.,, Immucor, Inc., Olerup SSp AB, QIAGEN, Inc, Bio-Rad Laboratories, Inc., Affymetrix, Inc., Illumina Inc., Luminex Corporation, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Inc., CareDx Inc, GenDx, Voden Medical Instruments S.p.a., TBG Diagnostics Limited, ProImmune Ltd, Pacific Biosciences of California, Inc, Omixon Inc., omicX, MC Diagnostics Ltd, Integrated Gulf Biosystems, InGen 5. What is the study period of this Market? Ans: The Global HLA Typing for Transplant Market is studied from 2022 to 2029.
HLA Typing for Transplant Market
Chapter 1 Research Methodology .1.1. Research Methodology .1.2. Market definition .1.3. Assumptions and Acronyms Used .1.4. Data Sources .1.4.1. Secondary .1.4.1.1. Paid .1.4.1.2. Unpaid .1.4.2. Primary Chapter 2 Executive Summary .2.1. HLA Typing for Transplant Market overview .2.1.1. By Technology .2.1.2. By Products Services .2.1.3. By Applications .2.1.4. By End Use Chapter 3 HLA Typing for Transplant Market Industry Insights .3.1. Market segmentation and scope of study .3.2. Market Drivers and their impact analysis .3.2.1. Market Drivers .3.2.1.1. Growing number of solid organ, soft tissue, and stem cell transplantations .3.3. Market share analysis .3.3.1. By Technology .3.3.2. By Products Services .3.3.3. By Applications .3.3.4. By End Use .3.4. Competitive analysis .3.4.1. Key strategic initiatives .3.4.2. Regional presence .3.4.3. Product overview .3.5. Porter’s analysis .3.6. PESTEL analysis Chapter 4 HLA Typing for Transplant Market, By End-Use .4.1. Key segment trends .4.2. Hospitals .4.2.1. Market size, by region, 2022 - 2029 .4.3. Academic Research Institute .4.3.1. Market size, by region, 2022 - 2029 Chapter 5 HLA Typing for Transplant Market, By Products .5.1. Key segment trends .5.2. Instruments .5.2.1. Market size, by region, 2022 - 2029 .5.3. Reagents .5.3.1. Market size, by region, 2022 - 2029 .5.4. Software .5.4.1. Market size, by region, 2022 - 2029 Chapter 6 HLA Typing for Transplant Market, By Application .6.1. Key segment trends .6.2. Diagnostics .6.2.1. Market size, by region, 2022 - 2029 .6.3. Research .6.3.1. Market size, by region, 2022 - 2029 Chapter 7 HLA Typing for Transplant Market, By Technology .7.1. Key segment trends .7.2. Non-Molecular Assays .7.2.1. Market size, by region, 2022 - 2029 .7.3. Serological Assays .7.3.1. Market size, by region, 2022 - 2029 .7.4. Mixed Lymphocyte Culture Assay .7.4.1. Market size, by region, 2022 - 2029 .7.5. Molecular Assays .7.5.1. Market size, by region, 2022 - 2029 .7.6. PCR based Molecular Assays .7.6.1. Market size, by region, 2022 - 2029 .7.7. Sequencing based molecular Assays .7.7.1. Market size, by region, 2022 - 2029 .7.8. Sanger Sequencing .7.8.1. Market size, by region, 2022 - 2029 .7.9. Next Generation Sequencing .7.9.1. Market size, by region, 2022 - 2029 Chapter 8 HLA Typing for Transplant Market, By Region .8.1. Key regional trends .8.2. North America .8.2.1. Market size, by country, 2022 - 2029 .8.2.2. Market size, by technology, 2022 - 2029 .8.2.3. Market size, by products, 2022 - 2029 .8.2.4. Market size, by end-use, 2022 - 2029 .8.2.5. Market size, by applications, 2022 - 2029 .8.3. U.S. .8.3.1. Market size, by technology, 2022 - 2029 .8.3.2. Market size, by products, 2022 - 2029 .8.3.3. Market size, by end-use, 2022 - 2029 .8.3.4. Market size, by applications, 2022 - 2029 .8.4. Canada .8.4.1. Market size, by technology, 2022 - 2029 .8.4.2. Market size, by products, 2022 - 2029 .8.4.3. Market size, by end-use, 2022 - 2029 .8.4.4. Market size, by applications, 2022 - 2029 .8.5. Europe .8.5.1. Market size, by country, 2022 - 2029 .8.5.2. Market size, by technology, 2022 - 2029 .8.5.3. Market size, by products, 2022 - 2029 .8.5.4. Market size, by end-use, 2022 - 2029 .8.5.5. Market size, by applications, 2022 - 2029 .8.6. Germany .8.6.1. Market size, by technology, 2022 - 2029 .8.6.2. Market size, by products, 2022 - 2029 .8.6.3. Market size, by end-use, 2022 - 2029 .8.6.4. Market size, by applications, 2022 - 2029 .8.7. UK .8.7.1. Market size, by technology, 2022 - 2029 .8.7.2. Market size, by products, 2022 - 2029 .8.7.3. Market size, by end-use, 2022 - 2029 .8.7.4. Market size, by applications, 2022 - 2029 .8.8. France .8.8.1. Market size, by technology, 2022 - 2029 .8.8.2. Market size, by products, 2022 - 2029 .8.8.3. Market size, by end-use, 2022 - 2029 .8.8.4. Market size, by applications, 2022 - 2029 .8.9. Spain .8.9.1. Market size, by technology, 2022 - 2029 .8.9.2. Market size, by products, 2022 - 2029 .8.9.3. Market size, by end-use, 2022 - 2029 .8.9.4. Market size, by applications, 2022 - 2029 .8.10. Italy .8.10.1. Market size, by technology, 2022 - 2029 .8.10.2. Market size, by products, 2022 - 2029 .8.10.3. Market size, by end-use, 2022 - 2029 .8.10.4. Market size, by applications, 2022 - 2029 .8.11. Sweden .8.11.1. Market size, by technology, 2022 - 2029 .8.11.2. Market size, by products, 2022 - 2029 .8.11.3. Market size, by end-use, 2022 - 2029 .8.11.4. Market size, by applications, 2022 - 2029 .8.12. Asia Pacific .8.12.1. Market size, by country, 2022 - 2029 .8.12.2. Market size, by technology, 2022 - 2029 .8.12.3. Market size, by products, 2022 - 2029 .8.12.4. Market size, by end-use, 2022 - 2029 .8.12.5. Market size, by applications, 2022 - 2029 .8.13. India .8.13.1. Market size, by technology, 2022 - 2029 .8.13.2. Market size, by products, 2022 - 2029 .8.13.3. Market size, by end-use, 2022 - 2029 .8.13.4. Market size, by applications, 2022 - 2029 .8.14. China .8.14.1. Market size, by technology, 2022 - 2029 .8.14.2. Market size, by products, 2022 - 2029 .8.14.3. Market size, by end-use, 2022 - 2029 .8.14.4. Market size, by applications, 2022 - 2029 .8.15. Japan .8.15.1. Market size, by technology, 2022 - 2029 .8.15.2. Market size, by products, 2022 - 2029 .8.15.3. Market size, by end-use, 2022 - 2029 .8.15.4. Market size, by applications, 2022 - 2029 .8.16. Australia .8.16.1. Market size, by technology, 2022 - 2029 .8.16.2. Market size, by products, 2022 - 2029 .8.16.3. Market size, by end-use, 2022 - 2029 .8.16.4. Market size, by applications, 2022 - 2029 .8.17. Latin America .8.17.1. Market size, by country, 2022 - 2029 .8.17.2. Market size, by technology, 2022 - 2029 .8.17.3. Market size, by products, 2022 - 2029 .8.17.4. Market size, by end-use, 2022 - 2029 .8.17.5. Market size, by applications, 2022 - 2029 .8.18. Argentina .8.18.1. Market size, by technology, 2022 - 2029 .8.18.2. Market size, by products, 2022 - 2029 .8.18.3. Market size, by end-use, 2022 - 2029 .8.18.4. Market size, by applications, 2022 - 2029 .8.19. Brazil .8.19.1. Market size, by technology, 2022 - 2029 .8.19.2. Market size, by products, 2022 - 2029 .8.19.3. Market size, by end-use, 2022 - 2029 .8.19.4. Market size, by applications, 2022 - 2029 .8.20. Mexico .8.20.1. Market size, by technology, 2022 - 2029 .8.20.2. Market size, by products, 2022 - 2029 .8.20.3. Market size, by end-use, 2022 - 2029 .8.20.4. Market size, by applications, 2022 - 2029 .8.21. Middle East and Africa .8.21.1. Market size, by country, 2022 - 2029 .8.21.2. Market size, by technology, 2022 - 2029 .8.21.3. Market size, by products, 2022 - 2029 .8.21.4. Market size, by end-use, 2022 - 2029 .8.21.5. Market size, by applications, 2022 - 2029 .8.22. South Africa .8.22.1. Market size, by technology, 2022 - 2029 .8.22.2. Market size, by products, 2022 - 2029 .8.22.3. Market size, by end-use, 2022 - 2029 .8.22.4. Market size, by applications, 2022 - 2029 .8.23. Saudi Arabia .8.23.1. Market size, by technology, 2022 - 2029 .8.23.2. Market size, by products, 2022 - 2029 .8.23.3. Market size, by end-use, 2022 - 2029 .8.23.4. Market size, by applications, 2022 - 2029 Chapter 9 Consolidations .9.1. Mergers and Acquisitions .9.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements .9.3. Patent Analysis Chapter 10 Company Profiles .10.1. Thermo Fischer Scientific, Inc. .10.1.1. Company overview .10.1.2. Key financials .10.1.3. Product landscape .10.1.4. Strategic initiatives .10.1.5. SWOT analysis .10.2. Immucor, Inc. .10.2.1. Company overview .10.2.2. Key financials .10.2.3. Product landscape .10.2.4. Strategic initiatives .10.2.5. SWOT analysis .10.3. Olerup SSp AB .10.3.1. Company overview .10.3.2. Key financials .10.3.3. Product landscape .10.3.4. Strategic initiatives .10.3.5. SWOT analysis .10.4. QIAGEN, Inc. .10.4.1. Company overview .10.4.2. Key financials .10.4.3. Product landscape .10.4.4. Strategic initiatives .10.4.5. SWOT analysis .10.5. Bio-Rad Laboratories, Inc. .10.5.1. Company overview .10.5.2. Key financials .10.5.3. Product landscape .10.5.4. Strategic initiatives .10.5.5. SWOT analysis .10.6. Affymetrix, Inc. .10.6.1. Company overview .10.6.2. Key financials .10.6.3. Product landscape .10.6.4. Strategic initiatives .10.6.5. SWOT analysis .10.7. Illumina Inc. .10.7.1. Company overview .10.7.2. Key financials .10.7.3. Product landscape .10.7.4. Strategic initiatives .10.7.5. SWOT analysis .10.8. Luminex Corporation .10.8.1. Company overview .10.8.2. Key financials .10.8.3. Product landscape .10.8.4. Strategic initiatives .10.8.5. SWOT analysis .10.9. F. Hoffmann-La Roche Ltd. .10.9.1. Company overview .10.9.2. Key financials .10.9.3. Product landscape .10.9.4. Strategic initiatives .10.9.5. SWOT analysis .10.10. Abbott Laboratories, Inc. .10.10.1. Company overview .10.10.2. Key financials .10.10.3. Product landscape .10.10.4. Strategic initiatives .10.10.5. SWOT analysis .10.11. GenDx .10.11.1. Company overview .10.11.2. Key financials .10.11.3. Product landscape .10.11.4. Strategic initiatives .10.11.5. SWOT analysis .10.12. CareDx .10.12.1. Company overview .10.12.2. Key financials .10.12.3. Product landscape .10.12.4. Strategic initiatives .10.12.5. SWOT analysis .10.13. Pacific Biosciences of California .10.13.1. Company overview .10.13.2. Key financials .10.13.3. Product landscape .10.13.4. Strategic initiatives .10.13.5. SWOT analysis